摘要
目的 探讨动脉硬化闭塞症(ASO) 与内皮素1(ET1) 、一氧化氮(NO) 等血管内皮细胞活性因子的相互关系。方法 选择96 例ASO 患者,采用密度梯度法检测循环内皮细胞计数(CEC),采用放射免疫测定法检测血浆ET1 、血栓素B2(TXB2)、6酮前列腺素F1α(6KPGF1α) ,降钙素基因相关肽(CGRP) 、血管紧张素Ⅱ(ATⅡ)、肿瘤坏死因子(TNF),采用酶联免疫检测细胞间粘附分子1(ICAM1)、P选择素(PS)。采用Griss 法检测血浆NO水平。结果 所有患者均存在高ET1、TXB2 、ATⅡ、粘附分子、CEC血症,存在低NO、CGRP、6KPGF1α血症,且以Ⅲ期病人最明显。结论 ASO 的发生发展同血管内皮细胞活性因子密切相关,ET1、NO 等血管活性因子的检测有助于ASO发病机制的探讨和病情严重程度的判别。
Objective To investigate the relationship between endothelial activity factors and atherosclerosis obliterans(ASO). Methods The plasma levels of endothelins 1 (ET 1), thromboxane B 2 (TXB 2), 6 ketto prostaglandin F1α (6 K PGF1α), calcium genetic related peptide (CGRP), tumor necrosis factor (TNF), intercellular adhesion molecule 1 (ICAM 1), P selectin (P S), angiotension Ⅱ (AT Ⅱ) were determined by using radioimmunoassy, Griss method and enzyme immunoassay respectively in 98 patients with ASO. Results The ASO patients had high levels of plasma ET 1, TXB2 and AT Ⅱ, low levels of plasma NO, CGRP and 6 K PGF1α, which were closely related with the stages of ASO. Conclusion The dysfunction of vascular endothelial cells was closely related with development of ASO. The determination of such vascular endothelial activity factor as ET 1, NO, etc. is helpful to investigate the mechanism of ASO and judge the severity of ASO.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
1999年第6期535-536,共2页
Chinese Journal of Experimental Surgery
基金
国家计委资助